Yazar "Tekbas, Serap" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    The assessment of quality of life in female Turkish patients with overactive bladder
    (Wiley, 2012) Sut, Hatice Kahyaoglu; Kaplan, Petek Balkanli; Sut, Necdet; Tekbas, Serap
    The objective of this study was to examine the quality of life in female Turkish patients with overactive bladder OAB). The investigation was conducted as a cross-sectional study between January and April 2010. Two hundred eighty female patients responded to the Overactive Bladder Validated Eight-Question Screener, the OAB disease-specific health-related quality-of-life scale OAB questionnaire OAB-q)) and the general quality-of-life scale EuroQol Five-Dimensional Questionnaire EQ-5D) for the study. Of the 280 patients, 38.9% was classified as having OAB. The mean age was 47.0 +/- 8.7. All of the quality-of-life domains coping, concern, sleep and social) and OAB-q total scores in women with OAB were significantly worse than in women without OAB P < 0.001 for all). Similarly, the EQ-5D(index) and EQ-5DVAS scores for women with OAB were significantly worse than for women without OAB P < 0.001 and P = 0.006, respectively). OAB-q and EQ-5D(index) scores in menopausal women were significantly lower than non-menopausal women P < 0.05) in patients with OAB. In conclusion, OAB negatively affects quality of life in Turkish women. However, many women's quality of life can be improved if the patients seek medical treatment. Thus, nurses should encourage the patients to seek medical support in order to cope with health-related quality-of-life problems.
  • Küçük Resim Yok
    Öğe
    The Effect of Treatment on Quality of Life, Symptoms, and Social Life in Gynecologic Cancer Patients
    (Sage Publications Inc, 2022) Tekbas, Serap; Sahin, Nevin Hotun; Sayin, Niyazi Cenk
    This study was carried out to determine the effect of treatment on quality of life, symptoms, and social life in patients with gynecologic cancer. Data were collected through face-to-face interviews to evaluate the individual and disease characteristics of the patients. The Edmonton Symptom Assessment Scale was used to determine the severity of the side effects. Functional Assessment of Cancer Therapy-General 4 was used to evaluate the quality of life. The total post-treatment quality of life scores of the patients were lower than their total pre-treatment scores. Patients who received chemotherapy and chemoradiotherapy had a lower quality of life than those who received radiotherapy, and they were less involved in social activities. Half of the individuals participated in social activities in the pre-treatment period, but this rate decreased to 16.4% after the treatment started. In this study, the quality-of-life scores of the patients who received gynecologic cancer treatment decreased after treatment and the patients experienced many symptoms at an increasingly severe level.